NCT03652480

Shoulder Corticosteroid Injection in Diabetic Patients

Efficacy and Safety of Subacromial Corticosteroid Injection in Type-2 Diabetic

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 20 (actual)
• Sponsor: University of Turin, Italy · Academic / Other
• Sex: All
• Age: 40 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

In type 2 diabetic patients affected by chronic shoulder pain, subacromial injection with corticosteroid could be an effective treatment. The aim of this study was to measure the risk-benefit ratio of this treatment.Twenty patients with well-controlled diabetes were included in a prospective study. In a first pre-injection phase, patients were asked to measure glycemia for 7 days, before breakfast and dinner, then 2 hours after lunch and dinner. Baseline data including Constant Score (CS), Subjective Shoulder Value (SSV) and Numerical Rating Scale (NRS) for pain were collected. Patients were treated with subacromial injection with 40mg of Methylprednisolone Acetate and 2ml of Lidocaine. At discharge, patients were asked to re-measured glycemia for the following week.

Conditions

• Shoulder Pain
• Corticosteroid Injection
• Type2 Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	MethylPREDNISolone Acetate 40 MG/ML

Timeline

• Start date: 2013-03-01
• Primary completion: 2014-03-01
• Completion: 2014-09-30
• First posted: 2018-08-29
• Last updated: 2018-08-31